POSTN in the TME promotes the direct binding of the transcription factor adaptor protein complex 2α (AP-2α) to the CD133 promoter region, thereby enhancing the expression of CD133 gene in HCC cells (Chen et al., 2021). The gene discussed is POSTN; the disease is hepatocellular carcinoma.